[go: up one dir, main page]

NO875025D0 - Blanding for aa stoppe angiogenese og kapillar-, celle- eller membranlekkasje. - Google Patents

Blanding for aa stoppe angiogenese og kapillar-, celle- eller membranlekkasje.

Info

Publication number
NO875025D0
NO875025D0 NO875025A NO875025A NO875025D0 NO 875025 D0 NO875025 D0 NO 875025D0 NO 875025 A NO875025 A NO 875025A NO 875025 A NO875025 A NO 875025A NO 875025 D0 NO875025 D0 NO 875025D0
Authority
NO
Norway
Prior art keywords
capillary
leakage
cellle
membranic
angiogenic
Prior art date
Application number
NO875025A
Other languages
English (en)
Other versions
NO875025L (no
Inventor
Larrian M D Gillespie
Original Assignee
Angiogenics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/020,859 external-priority patent/US4820693A/en
Application filed by Angiogenics Ltd filed Critical Angiogenics Ltd
Publication of NO875025L publication Critical patent/NO875025L/no
Publication of NO875025D0 publication Critical patent/NO875025D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
NO875025A 1986-04-04 1987-12-02 Blanding for aa stoppe angiogenese og kapillar-, celle- eller membranlekkasje. NO875025D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84828886A 1986-04-04 1986-04-04
US86598186A 1986-05-22 1986-05-22
US07/020,859 US4820693A (en) 1986-05-22 1987-03-02 Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
PCT/US1987/000704 WO1987005808A1 (en) 1986-04-04 1987-04-03 Composition for arresting angiogenesis and capillary, cell or membrane leakage

Publications (2)

Publication Number Publication Date
NO875025L NO875025L (no) 1987-12-02
NO875025D0 true NO875025D0 (no) 1987-12-02

Family

ID=27361529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875025A NO875025D0 (no) 1986-04-04 1987-12-02 Blanding for aa stoppe angiogenese og kapillar-, celle- eller membranlekkasje.

Country Status (7)

Country Link
EP (1) EP0299975B1 (no)
AT (1) ATE82126T1 (no)
AU (1) AU600271B2 (no)
DE (1) DE3782652D1 (no)
DK (1) DK634987D0 (no)
NO (1) NO875025D0 (no)
WO (1) WO1987005808A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
JP2511829B2 (ja) * 1987-03-19 1996-07-03 アースロファーム ピーティーワイ.リミティッド 抗炎症作用のある化合物および組成物
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5021404A (en) * 1988-04-20 1991-06-04 The Children's Medical Center Corporation Angiostatic collagen modulators
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JPH07500843A (ja) * 1991-11-11 1995-01-26 ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルバニア 再狭窄を抑制する方法
KR102472214B1 (ko) 2018-02-28 2022-11-30 삼성전자주식회사 에어 컨디셔닝 시스템에서 복합 제어 장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3373782D1 (en) * 1982-12-20 1987-10-29 Harvard College Inhibition of angiogenesis

Also Published As

Publication number Publication date
EP0299975A4 (en) 1989-10-25
DK634987A (da) 1987-12-03
EP0299975B1 (en) 1992-11-11
NO875025L (no) 1987-12-02
AU600271B2 (en) 1990-08-09
AU7286287A (en) 1987-10-20
DK634987D0 (da) 1987-12-03
DE3782652D1 (de) 1992-12-17
ATE82126T1 (de) 1992-11-15
EP0299975A1 (en) 1989-01-25
WO1987005808A1 (en) 1987-10-08

Similar Documents

Publication Publication Date Title
IS3644A7 (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
FI864665A (fi) Lääkeaineille tarkoitettuja kantajakoostumuksia, jotka sisältävät hydroksipropyyliselluloosaeettereitä
ATE71288T1 (de) Mischmicell-loesungen mit nichtsteroidalen entzuendungshemmern.
NO178095C (no) Fremgangsmåte for fremstilling av et omhyllet farmasöytisk retarderingspreparat
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
FI801614A (fi) Farmaceutiskt preparat i form av en polyakrylatfilm
NO160330C (no) Anordning for aa administrere medikamenter til pasienter og medikamentpakning for anordningen.
AU3284984A (en) Pharmaceutical compositions for the transdermal application of active ingredients
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
NL190693C (nl) Stabiel, prostaglandine bevattend, farmaceutisch preparaat.
DK0533213T3 (da) Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasis
NO875025D0 (no) Blanding for aa stoppe angiogenese og kapillar-, celle- eller membranlekkasje.
EP0177342A3 (en) Oral formulation of therapeutic proteins
SE8603481L (sv) Topisk stralskyddsgel for mukosa
DK69685A (da) Oralt praeparat, der indeholder allergen
ES2059312T3 (es) Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
DK183582A (da) Fremgangsmaade til fremstilling af oxazolderivater
SE8501312D0 (sv) Etoposide oral dosage form
DK68388A (da) Anvendelse af oxochinazolinderivater til fremstilling af laegemidler til behandling af hyperurikaemi
IT8220537A0 (it) Derivati della cefuroxima attivi per via orale procedimenti per laloro preparazione e relative composizioni farmaceutuche.
DK92183A (da) 11beta-chlor-delta15-steroider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater med indhold heraf
IT1172154B (it) Piroglutammil-triptofano e suoi derivati,procedimento per la sua preparazione e sue applicazioni terapeutiche
IT8121788A0 (it) Derivati della dregamina, procedimento per la loro preparazione, composizioni farmaceutiche che li contengono eloro impiego terapeutico.
NO880356D0 (no) Doseringsenhet for absorpsjon av oestradiol og andre oestrogene stereoider gjennom huden, samt fremgangsmaate til administrering av stereoidene.